Tumour necrosis factor (TNF) receptor family (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

David MacEwan

doi:10.2218/gtopdb/F334/2019.4

Tumour necrosis factor (TNF) receptor family (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

Authors

David MacEwan University of Liverpool https://orcid.org/0000-0002-2879-0935

DOI:

https://doi.org/10.2218/gtopdb/F334/2019.4

Abstract

Dysregulated TNFR signalling is associated with many inflammatory disorders, including some forms of arthritis and inflammatory bowel disease, and targeting TNF has been an effective therapeutic strategy in these diseases and for cancer immunotherapy [4, 5, 38].

Downloads

GtoPdb Database
PDF
HTML

Published

16-Sep-2019

How to Cite

MacEwan, D. (2019) “Tumour necrosis factor (TNF) receptor family (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database”, IUPHAR/BPS Guide to Pharmacology CITE, 2019(4). doi: 10.2218/gtopdb/F334/2019.4.